MAPT and Alzheimer disease: Furthermore, the presence of an N-terminal pathological fragment of tau from 26–230 amino acids in AD patients was found to decrease the proliferation of neuroprogenitor cells and the long-term survival of newborn neurons in the adult SGZ [59].